Daniel J. Lippis
CVP, TAVR · Edwards Lifesciences Corp
IndividualSelling only38 10b5-1 trades
- 2024
- Oct 8, 2026
- 22
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel J. Lippis files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Donald E. Bobo Jr. - $8.28M in EW purchases and sales in the last 12 months
- Scott B. Ullem - $3.22M in EW purchases and sales in the last 12 months
- Daveen Chopra - $3.02M in EW purchases and sales in the last 12 months
- Bernard J. Zovighian - $2.01M in EW purchases and sales in the last 12 months
- Wayne Markowitz - $992K in EW purchases and sales in the last 12 months
- Annette Bruls - $238K in EW purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Daniel J. Lippis?
Daniel J. Lippis is a corporate insider, tracked as CVP, TAVR of Edwards Lifesciences Corp (EW). InsiderAlpha holds 22 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Daniel J. Lippis submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Daniel J. Lippis been buying or selling stock?
Recorded transactions: 0 open-market purchases and 16 open-market sales ($1.31M) across all tracked filings.
